Title : Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma.

Pub. Date : 2014 Jan

PMID : 24362935






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Transcriptome sequencing revealed genetic lesions in alternative NF-kappaB pathway signaling components in ibrutinib-insensitive cell lines, and sequencing of 165 samples from patients with MCL identified recurrent mutations in TRAF2 or BIRC3 in 15% of these individuals. ibrutinib nuclear factor kappa B subunit 1 Homo sapiens
2 Although they are associated with insensitivity to ibrutinib, lesions in the alternative NF-kappaB pathway conferred dependence on the protein kinase NIK (also called mitogen-activated protein 3 kinase 14 or MAP3K14) both in vitro and in vivo. ibrutinib nuclear factor kappa B subunit 1 Homo sapiens